Research Article

Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura)

Volume: 18 Number: 2 March 18, 2024
EN TR

Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura)

Abstract

Objective: Immunoglobulin A vasculitis (Henoch-Schönlein Purpura) is the most common systemic vasculitis of childhood involving the skin, joints, gastrointestinal tract, and kidneys, and less frequently affects other systems. In this study, we aimed to evaluate the epidemiologic, clinical, and laboratory findings of pediatric patients with IgA vasculitis. Material and Methods: In this study, 366 patients diagnosed with IgA vasculitis (Henoch-Schönlein Purpura) in the pediatric nephrology clinic were retrospectively analyzed. Demographic characteristics, clinical findings, system involvement, and laboratory findings were recorded. Results: Of the patients in the study, 57.9% (212) were male and the male-to-female ratio was 1.37. The most common age group was found to be between 5-9 years of age. A statistically significant correlation existed between age and renal involvement (p<0.001). It was found that renal involvement increased with increasing age. Gastrointestinal system involvement was statistically significantly higher in the male gender (p=0.003). A statistically significant correlation existed between increased leukocyte counts, gastrointestinal system involvement, and renal involvement (p=0.001, p=0.009, respectively). Conclusion: Age and increased leukocyte count were found to be risk factors for renal involvement. Male gender and increased leukocyte count were found to be risk factors for gastrointestinal system involvement.

Keywords

References

  1. Leung AKC, Barankin B, Leong KF. Henoch-Schönlein Purpura in Children: An Updated Review. Curr Pediatr Rev 2020;16:265-76.
  2. Roberts PF, Waller TA, Brinker TM, Riffe IZ, Sayre JW, Bratton RL. Henoch-Schönlein purpura: a review article. South Med J 2007;100:821-4.
  3. Rostoker G. Schönlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001;15:99-138.
  4. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010;69:798-806.
  5. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012;Suppl 2:1-138.
  6. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
  7. Di Pietro GM, Castellazzi ML, Mastrangelo A, Montini G, Marchisio P, Tagliabue C. Henoch-Schönlein Purpura in children: not only kidney but also lung. Pediatr Rheumatol Online J 2019;17:75.
  8. Dedeoglu F, Sundel RP. Vasculitis in children. Pediatr Clin North Am 2005;52:547-75, vii.

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Early Pub Date

January 4, 2024

Publication Date

March 18, 2024

Submission Date

October 10, 2023

Acceptance Date

November 28, 2023

Published in Issue

Year 2024 Volume: 18 Number: 2

APA
Eryılmaz Polat, S., Özlü, S. G., Kargın Çakıcı, E., Aydoğ, Ö., & Bülbül, M. (2024). Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura). Türkiye Çocuk Hastalıkları Dergisi, 18(2), 111-116. https://doi.org/10.12956/tchd.1361962
AMA
1.Eryılmaz Polat S, Özlü SG, Kargın Çakıcı E, Aydoğ Ö, Bülbül M. Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura). Turkish J Pediatr Dis. 2024;18(2):111-116. doi:10.12956/tchd.1361962
Chicago
Eryılmaz Polat, Sanem, Sare Gülfem Özlü, Evrim Kargın Çakıcı, Özlem Aydoğ, and Mehmet Bülbül. 2024. “Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients With IgA Vasculitis (Henoch-Schönlein Purpura)”. Türkiye Çocuk Hastalıkları Dergisi 18 (2): 111-16. https://doi.org/10.12956/tchd.1361962.
EndNote
Eryılmaz Polat S, Özlü SG, Kargın Çakıcı E, Aydoğ Ö, Bülbül M (March 1, 2024) Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura). Türkiye Çocuk Hastalıkları Dergisi 18 2 111–116.
IEEE
[1]S. Eryılmaz Polat, S. G. Özlü, E. Kargın Çakıcı, Ö. Aydoğ, and M. Bülbül, “Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura)”, Turkish J Pediatr Dis, vol. 18, no. 2, pp. 111–116, Mar. 2024, doi: 10.12956/tchd.1361962.
ISNAD
Eryılmaz Polat, Sanem - Özlü, Sare Gülfem - Kargın Çakıcı, Evrim - Aydoğ, Özlem - Bülbül, Mehmet. “Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients With IgA Vasculitis (Henoch-Schönlein Purpura)”. Türkiye Çocuk Hastalıkları Dergisi 18/2 (March 1, 2024): 111-116. https://doi.org/10.12956/tchd.1361962.
JAMA
1.Eryılmaz Polat S, Özlü SG, Kargın Çakıcı E, Aydoğ Ö, Bülbül M. Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura). Turkish J Pediatr Dis. 2024;18:111–116.
MLA
Eryılmaz Polat, Sanem, et al. “Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients With IgA Vasculitis (Henoch-Schönlein Purpura)”. Türkiye Çocuk Hastalıkları Dergisi, vol. 18, no. 2, Mar. 2024, pp. 111-6, doi:10.12956/tchd.1361962.
Vancouver
1.Sanem Eryılmaz Polat, Sare Gülfem Özlü, Evrim Kargın Çakıcı, Özlem Aydoğ, Mehmet Bülbül. Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura). Turkish J Pediatr Dis. 2024 Mar. 1;18(2):111-6. doi:10.12956/tchd.1361962


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.